Drawing for MEDITERRANEAN NUTRITION SCIENCE

USPTO serial 79418152

MEDITERRANEAN NUTRITION SCIENCE

Reviewed by CopyMark Law Group

Reg. 8268411Status 700Registered
Filing date
Status date
Registration date
May 26, 2026
Examiner
NISHIGAYA, CHRISTINE EIKO
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MEDITERRANEAN NUTRITION SCIENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Larry H. Tronco

Larry H. Tronco Holland & Hart, LLPPO Box 8749Trademark DocketingDenver, CO 80201

Goods and services

ClassDescriptionStatusFirst use
001Chemical and organic compositions, namely, antioxidants, cellobiose, and allulose for use in the manufacture of food and beverages; Chemical additives in the nature of chemical substances, chemical materials and preparations, and natural elements for use in the manufacture of pharmaceutical products, food supplements and cosmetics; Chemical compounds and materials for use in science, namely, reagents for scientific use; Chemical compounds and materials being additives for use in the manufacture of cosmetics; Active chemical ingredients for use in the manufacture of pharmaceuticals; Plant extracts, other than essential oils, for use in the manufacture of pharmaceutical products; Vitamins for use in the manufacture of pharmaceutical products; Chemical additives for use in the manufacture of food supplements; Plant extracts, other than essential oils, for use in the manufacture of food supplements; Plant extracts, other than essential oils, for use in the food industry, namely, plant extracts in the manufacture of foods; Plant extracts, other than essential oils, for use in the manufacture of cosmetics; Botanical extracts, other than essential oils, for the manufacture of cosmeticsACTIVE—
003Cosmetic preparations; Perfume oils for the manufacture of cosmetic preparations; Essential oils and aromatic extracts being aromatic essential oils; Cleansing and perfuming preparations being perfume oils; cosmetic body care preparations and beauty care preparations in the nature of beauty care cosmetics; perfumery and fragrances; cosmetic oils; cosmetics and cosmetic preparations; toiletries namely, non-medicated toiletry preparationsACTIVE—
005Pharmaceutical preparations and natural medicines in nature of medicinal herbal preparations for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, immune system deficiencies, allergies, hypovitaminosis, cognitive impairment, mental disorders, sleep disorders, musculoskeletal aches, osteoarticular disorders, skin disorders, nails and hair disorders, electrolyte imbalances, anemia, mineral deficiency, headaches, urogenital disorders, gynecological disorders, infertility, dental disorders, hepatobiliary disorders, pancreatic disorders, liver disease, obesity, diabetes, eye disease, respiratory system disease, ulcers, and tissue trauma; Food supplements and dietary preparations, namely, dietary supplements for the treatment of cardiometabolic and cardiovascular risk factors, vascular disease, gastrointestinal disorders, inflammation and edema of tissues, flu, cough and cold, fatigue, malnutrition, sarcopenia, immune system deficiencies, allergies, hypovitaminosis, cognitive impairment, mental disorders, sleep disorders, musculoskeletal aches, osteoarticular disorders, skin disorders, nails and hair disorders, electrolyte imbalances, anemia, mineral deficiency, headaches, urogenital disorders, gynecological disorders, infertility, dental disorders, hepatobiliary disorders, pancreatic disorders, liver disease, obesity, diabetes, eye disease, respiratory system disease, ulcers, and tissue trauma; Pharmaceutical skin lotions; Dermatological pharmaceutical productsACTIVE—
041Educational services, namely, providing seminars and online courses of instruction in the field of health and nutrition; Book publishing and editing services; Organization of conferences and exhibitions in the field of health and nutrition for educational purposes; rental of audiovisual equipment and performing arts facilities for the production of educational eventsACTIVE—
042Pharmaceutical research services; Pharmaceutical and drug product development; Pharmaceutical research and development; Conducting clinical studies in the nature of scientific clinical trial research for others in the field of pharmaceutical products; Pharmaceutical research and development consultancy; Technical consultancy in relation to research services relating to food and dietary supplementsACTIVE—
044Dietary and nutritional advice in the form of guidance; Provision of health information in the field of dietary and nutritional supplements; Provision of health information relating to dietary and nutritional guidance; Medical assistanceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 26, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 13, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jul 27, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 26, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 23, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 26, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 26, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 26, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 26, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 7, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 2, 2026GPNXNOTIFICATION PROCESSED BY IB—
Apr 1, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 18, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 10, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 10, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Mar 10, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 10, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 10, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 4, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 4, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 4, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2025RFNTREFUSAL PROCESSED BY IB—
Aug 4, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 4, 2025RFRRREFUSAL PROCESSED BY MPU—
Jun 14, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 13, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 11, 2025RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Jun 11, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 10, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2025RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Apr 3, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 2, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2025DOCKASSIGNED TO EXAMINER—
Mar 25, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 25, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 21, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 27, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance